COX-2 selective inhibitors and heart health

被引：0
|
作者：
Simon, Lee S. [3 ,4 ]
White, William B. [1 ,2 ]
机构：
[1] Univ Connecticut, Ctr Hlth, Clin Trials Unit, Farmington, CT 06030 USA
[2] Univ Connecticut, Sch Med, Calhoun Cardiol Ctr, Farmington, CT 06030 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
来源：
POSTGRADUATE MEDICINE | 2005年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
On September 30, 2004, because of an observed increased risk of serious cardiovascular (CV) events, Merck & Co, Inc, voluntarily withdrew rofecoxib from the worldwide market. The withdrawal has focused attention on the possible class effect on the cardiovascular system of the other currently available cyclooxygenase-2 (COX-2) selective inhibitors: celecoxib and valdecoxib. This review evaluates and differentiates the CV effects of COX-2 selective inhibitors through an assessment of prospective, randomized epidemiologic studies and meta-analyses.
引用
收藏
页码：7 / 20
页数：14
相关论文
共 50 条
  • [21] Are COX-2 selective inhibitors effective analgesics?
    McCormack, K
    Twycross, R
    PAIN REVIEWS, 2001, 8 (01): : 13 - 26
  • [22] Decisions loom on selective COX-2 inhibitors
    Miller, JL
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (02) : 106 - 107
  • [23] Clinical pharmacology of selective COX-2 inhibitors
    Capone, ML
    Tacconelli, S
    Sciulli, MG
    Patrignani, P
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2003, 16 (02) : 49 - 58
  • [24] Selective COX-2 inhibitors are safe and effective
    Beales, Ian L. P.
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 368
  • [25] Attitude before COX-2 selective inhibitors
    Zaragoza, JL
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2005, 57 (01): : 6 - 12
  • [26] COX-2 Selective Inhibitors in the Treatment of Osteoarthritis
    Laine, Loren
    White, William B.
    Rostom, Alaa
    Hochberg, Marc
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2008, 38 (03) : 165 - 187
  • [27] Gastrointestinal safety of selective COX-2 inhibitors
    Hawkey, CJ
    Skelly, MM
    CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (12) : 1077 - 1089
  • [28] SYNTHESIS AND PHARMACOLOGY OF SELECTIVE COX-2 INHIBITORS
    ISAKSON, P
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 270 - MEDI
  • [29] Renaissance of the Selective COX-2 Inhibitors (Coxibes)?
    Fischbach, W.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2011, 49 (09): : 1342 - 1344
  • [30] Selective COX-2 inhibitors: potentials and limits
    Pairet, M
    Netter, P
    THERAPIE, 1999, 54 (04): : 433 - 445
12345